PETALING JAYA: Hong Seng Consolidated Bhd, via its wholly-owned subsidiary HS Bio Supplies Sdn Bhd, has acquired 51% stake in Pantasniaga Sdn Bhd, which has been supplying polymerase chain reaction (PCR) test kits for Covid-19.
In a statement yesterday, Hong Seng said Pantasniaga has the know-how and experience to build test labs for the Covid-19 test screening samples.
“HS Bio has been working hard into its foray in the healthcare sector. Through the acquisition of Pantasniaga, HS Bio will be involved in serving the nation to help government agencies procure PCR test kits for Sabah’s Covid-19 outbreak.”
As Pantasniaga has already performed and fulfilled a few supply contracts for Malaysian government agencies, Hong Seng said HS Bio would be continuing its support to procure and supply the PCR test kits with the ongoing outbreak in Malaysia, as well as neighbouring countries.
Pantasniaga has also received letters of offer and secured a supply contract of RM25mil to a Malaysian government agency to curb the immediate crisis in Sabah.
Did you find this article insightful?
100% readers found this article insightful